Cargando…

Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory‐confirmed influenza in hospitalised children aged 6–59 months

Please cite this paper as: Dixon et al. (2010) Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory‐confirmed influenza in hospitalised children aged 6–59 months. Influenza and Other Respiratory Viruses 4(4), 231–234. Background ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, Gabriela A, Moore, Hannah C, Kelly, Heath, Jacoby, Peter, Carcione, Dale, Williams, Simon, Smith, David, Keil, Anthony D, Van Buynder, Paul, Richmond, Peter C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964547/ https://www.ncbi.nlm.nih.gov/pubmed/20629773 http://dx.doi.org/10.1111/j.1750-2659.2010.00141.x

Ejemplares similares

Marketing paediatric influenza vaccination: results of a major metropolitan trial
por: Van Buynder, Paul G., et al.
Publicado: (2010)

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17
por: Mira-Iglesias, Ainara, et al.
Publicado: (2018)

Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season
por: Mira-Iglesias, Ainara, et al.
Publicado: (2019)

Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015–2016 influenza season – a test-negative case–control study
por: Boddington, N. L., et al.
Publicado: (2019)

Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study
por: Cheng, Allen C., et al.
Publicado: (2013)

Platelet Abnormalities in Children with Laboratory-Confirmed Influenza
por: Wrotek, August, et al.
Publicado: (2023)

Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season
por: Pebody, Richard, et al.
Publicado: (2017)

Waived Consent in Perinatal/Neonatal Research—When Is It Appropriate?
por: Rich, Wade D., et al.
Publicado: (2019)

730. Hospital Readmissions Following Laboratory-Confirmed Influenza
por: Dobrzynski, David, et al.
Publicado: (2018)

Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada
por: Hinds, Aynslie M, et al.
Publicado: (2015)

Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
por: Niazi, Sarfaraz
Publicado: (2022)

Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013()
por: El Omeiri, Nathalie, et al.
Publicado: (2018)

1341 The benefit of early influenza antiviral treatment of pregnant women hospitalized with laboratory-confirmed influenza
por: Oboho, Ikwo, et al.
Publicado: (2014)

Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali
por: Buchwald, Andrea G., et al.
Publicado: (2019)

1161. Effectiveness of the Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Infections in Outpatient Immunocompromised Adults, 2017-2018
por: Kramer, Kailey Hughes, et al.
Publicado: (2023)

Elementary School-Based Influenza Vaccination: Evaluating Impact on Respiratory Illness Absenteeism and Laboratory-Confirmed Influenza
por: Kjos, Sonia A., et al.
Publicado: (2013)

The Association between Influenza Treatment and Hospitalization-Associated Outcomes among Korean Children with Laboratory-Confirmed Influenza
por: Lim, Jacqueline K., et al.
Publicado: (2014)

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Evaluation of obesity as an independent risk factor for medically attended laboratory‐confirmed influenza
por: Coleman, Laura A., et al.
Publicado: (2012)

Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis
por: Woolpert, Tabitha, et al.
Publicado: (2012)

Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF)
por: Sin, Phyllis, et al.
Publicado: (2022)

Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain
por: Derqui, Nieves, et al.
Publicado: (2022)

The impact of influenza infection on young children, their family and the health care system
por: Willis, Gabriela A., et al.
Publicado: (2018)

Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities
por: Moa, Aye, et al.
Publicado: (2023)

Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure
por: Carballo, David, et al.
Publicado: (2021)

Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza
por: Sorey, Woody, et al.
Publicado: (2023)

Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010–2013
por: Ho, Hin Peow, et al.
Publicado: (2014)

Medicare Second Surgical Opinion Programs: The Effect of Waiving Cost-Sharing
por: Friedlob, Alan S.
Publicado: (1982)

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities
por: Klepser, Nicklas S., et al.
Publicado: (2021)

Parental Perspectives on a Trial Using Waived Informed Consent at Birth
por: Katheria, Anup, et al.
Publicado: (2023)

Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children
por: Van Buynder, P. G., et al.
Publicado: (2010)

Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh
por: Rolfes, Melissa A., et al.
Publicado: (2017)

Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan
por: Suzuki, Motoi, et al.
Publicado: (2018)

Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
por: Kotecha, Rishi S., et al.
Publicado: (2015)

Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review
por: Fell, Deshayne B, et al.
Publicado: (2017)

Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection
por: Chorazka, Magdalena, et al.
Publicado: (2021)

Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment
por: Shihabuddin, Bashar S., et al.
Publicado: (2022)

Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study
por: Steens, Anneke, et al.
Publicado: (2011)

Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination
por: Van Buynder, Paul G., et al.
Publicado: (2012)

899. Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children Hospitalized with Respiratory Illness in the United States, 2016–2017 and 2017–2018 Seasons
por: Campbell, Angela P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e7rn5tpvidbglpcvg0c60urheg